Recall Register

Device recall: Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use

Class II FDA enforcement event 91001. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Abbott has identified potential performance issues for the Alinity m System software version 1.6.5: 1) In a unique scenario, the waste chute flapper was found to not open when the Systems Solution drawer was closed and locked. It was found that the software will cause the flapper door to stay in the closed position when the drawer is closed and locked if the flapper had previously been moved out…

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Abbott Molecular, Inc. started this device recall on 12 Oct 2022. The firm address in the FDA record is in Des Plaines, IL. FDA put the recall in Class II. FDA event 91001 has 1 product record. The first FDA enforcement report date is 30 Nov 2022. The record gives the status Ongoing. 254 of the 839 device events that started in 2022 have more product records. The median device event of 2022 has 1 product record. The openFDA file has 839 device events that started in 2022 and 900 that started in 2021.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Worldwide distribution.

Recalling firm

Abbott Molecular, Inc., Des Plaines, IL.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 91001: product records
Recall numberProductQuantityClassStatusReport date
Z-0268-2023Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use883 unitsClass IIOngoing30 Nov 2022

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2022
839
Share of these events in Class II
88%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
20

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 91001. https://recallregister.com/fda/ii/91001/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Worldwide distribution.
What quantity of product is in FDA event 91001?
The FDA record gives this quantity: 883 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2022 have the same class?
88% of the 839 device events that started in 2022 are in Class II.